Tauroursodeoxycholic acid reduces bile acid-induced apoptosis by modulation of AP-1

Biochemical and Biophysical Research Communications

Volumn 367, Issue 1, 2008, Pages 208-212

  Pusl, Thomas ^a   Vennegeerts, Timo ^a   Wimmer, Ralf ^a   Denk, Gerald U ^a   Beuers, Ulrich ^b   Rust, Christian ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

AP 1; Apoptosis; cFos; Cholestasis; JunB; Liver; Signal transduction; Taurolithocholic acid; Tauroursodeoxycholic acid

Indexed keywords

BILE ACID; PROTEIN C FOS; TAUROLITHOLIC ACID; TAUROURSODEOXYCHOLIC ACID; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR JUNB; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

APOPTOSIS; BASE SEQUENCE; BILE ACIDS AND SALTS; CELLS, CULTURED; CHOLAGOGUES AND CHOLERETICS; CHOLESTASIS; HUMANS; LIVER DISEASES; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; TAUROCHENODEOXYCHOLIC ACID; TAUROLITHOCHOLIC ACID; TRANSCRIPTION FACTOR AP-1;

EID: 38049021096     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.12.122     Document Type: Article

References (36)

1. Hofmann A.F. Cholestatic liver disease: pathophysiology and therapeutic options. Liver 22 Suppl 2 (2002) 14-19
2. Koga H., Sakisaka S., Ohishi M., Sata M., and Tanikawa K. Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis. Hepatology 25 (1997) 1077-1084
3. Rust C., Karnitz L.M., Paya C.V., Moscat J., Simari R.D., and Gores G.J. The bile acid taurochenodeoxycholate activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J. Biol. Chem. 275 (2000) 20210-20216
4. Reinehr R., Becker S., Keitel V., Eberle A., Grether-Beck S., and Haussinger D. Bile salt-induced apoptosis involves NADPH oxidase isoform activation. Gastroenterology 129 (2005) 2009-2031
5. Graf D., Kurz A.K., Fischer R., Reinehr R., and Haussinger D. Taurolithocholic acid-3 sulfate induces CD95 trafficking and apoptosis in a c-Jun N-terminal kinase-dependent manner. Gastroenterology 122 (2002) 1411-1427
6. Rodrigues C.M., Fan G., Wong P.Y., Kren B.T., and Steer C.J. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol. Med. 4 (1998) 165-178
7. Reinehr R., Graf D., and Haussinger D. Bile salt-induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95 tyrosine phosphorylation. Gastroenterology 125 (2003) 839-853
8. Shaulian E., and Karin M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4 (2002) E131-E136
9. Shaulian E., and Karin M. AP-1 in cell proliferation and survival. Oncogene 20 (2001) 2390-2400
10. Bernt C., Vennegeerts T., Beuers U., and Rust C. The human transcription factor AP-1 is a mediator of bile acid-induced liver cell apoptosis. Biochem. Biophys. Res. Commun. 340 (2006) 800-806
11. Rust C., and Beuers U. Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis. Clin. Rev. Allergy Immunol. 28 (2005) 135-145
12. Benz C., Angermuller S., Otto G., Sauer P., Stremmel W., and Stiehl A. Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes. Eur. J. Clin. Invest. 30 (2000) 203-209
13. Rodrigues C.M., Fan G., Ma X., Kren B.T., and Steer C.J. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J. Clin. Invest. 101 (1998) 2790-2799
14. Glasova H., Berghaus T.M., Kullak-Ublick G.A., Paumgartner G., and Beuers U. Tauroursodeoxycholic acid mobilizes alpha-PKC after uptake in human HepG2 hepatoma cells. Eur. J. Clin. Invest. 32 (2002) 437-442
15. Czaja M.J. The future of GI and liver research: editorial perspectives. III. JNK/AP-1 regulation of hepatocyte death. Am. J. Physiol. Gastrointest. Liver Physiol. 284 (2003) G875-G879
16. Dickinson D.A., Iles K.E., Zhang H., Blank V., and Forman H.J. Curcumin alters EpRE and AP-1 binding complexes and elevates glutamate-cysteine ligase gene expression. FASEB J. 17 (2003) 473-475
17. Shishodia S., Singh T., and Chaturvedi M.M. Modulation of transcription factors by curcumin. Adv. Exp. Med. Biol. 595 (2007) 127-148
18. Chen Y.R., and Tan T.H. Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene 17 (1998) 173-178
19. Sokol R.J., Straka M.S., Dahl R., Devereaux M.W., Yerushalmi B., Gumpricht E., Elkins N., and Everson G. Role of oxidant stress in the permeability transition induced in rat hepatic mitochondria by hydrophobic bile acids. Pediatr. Res. 49 (2001) 519-531
20. Higuchi H., Yoon J.H., Grambihler A., Werneburg N., Bronk S.F., and Gores G.J. Bile acids stimulate cFLIP phosphorylation enhancing TRAIL-mediated apoptosis. J. Biol. Chem. 278 (2003) 454-461
21. Miyoshi H., Rust C., Roberts P.J., Burgart L.J., and Gores G.J. Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology 117 (1999) 669-677
22. Sokol R.J., Winklhofer-Roob B.M., Devereaux M.W., and McKim Jr. J.M. Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids. Gastroenterology 109 (1995) 1249-1256
23. Yerushalmi B., Dahl R., Devereaux M.W., Gumpricht E., and Sokol R.J. Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition. Hepatology 33 (2001) 616-626
24. Hirano F., Tanada H., Makino Y., Okamoto K., Hiramoto M., Handa H., and Makino I. Induction of the transcription factor AP-1 in cultured human colon adenocarcinoma cells following exposure to bile acids. Carcinogenesis 17 (1996) 427-433
25. Glinghammar B., Holmberg K., and Rafter J. Effects of colonic lumenal components on AP-1-dependent gene transcription in cultured human colon carcinoma cells. Carcinogenesis 20 (1999) 969-976
26. Hess J., Angel P., and Schorpp-Kistner M. AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci. 117 (2004) 5965-5973
27. Eferl R., and Wagner E.F. AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3 (2003) 859-868
28. Sola S., Amaral J.D., Aranha M.M., Steer C.J., and Rodrigues C.M. Modulation of hepatocyte apoptosis: cross-talk between bile acids and nuclear steroid receptors. Curr. Med. Chem. 13 (2006) 3039-3051
29. Guicciardi M.E., and Gores G.J. Ursodeoxycholic acid cytoprotection: dancing with death receptors and survival pathways. Hepatology 35 (2002) 971-973
30. Benz C., Angermuller S., Tox U., Kloters-Plachky P., Riedel H.D., Sauer P., Stremmel W., and Stiehl A. Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes. J. Hepatol. 28 (1998) 99-106
31. Rodrigues C.M., Ma X., Linehan-Stieers C., Fan G., Kren B.T., and Steer C.J. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. Cell Death Differ. 6 (1999) 842-854
32. Rodrigues C.M., Sola S., Sharpe J.C., Moura J.J., and Steer C.J. Tauroursodeoxycholic acid prevents Bax-induced membrane perturbation and cytochrome C release in isolated mitochondria. Biochemistry 42 (2003) 3070-3080
33. Sola S., Ma X., Castro R.E., Kren B.T., Steer C.J., and Rodrigues C.M. Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in transforming growth factor beta1-induced apoptosis of rat hepatocytes. J. Biol. Chem. 278 (2003) 48831-48838
34. Amaral J.D., Castro R.E., Sola S., Steer C.J., and Rodrigues C.M. p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis. J Biol. Chem. 282 (2007) 34250-34259
35. Schoemaker M.H., Conde d.l.R., Buist-Homan M., Vrenken T.E., Havinga R., Poelstra K., Haisma H.J., Jansen P.L., and Moshage H. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology 39 (2004) 1563-1573
36. Im E., and Martinez J.D. Ursodeoxycholic acid (UDCA) can inhibit deoxycholic acid (DCA)-induced apoptosis via modulation of EGFR/Raf-1/ERK signaling in human colon cancer cells. J. Nutr. 134 (2004) 483-486